Josiah Macy, Jr. Foundation
2027 Macy Faculty Scholars Program

Deadline: July 30, 2026, 11:59 PM

Funding:

• Salary support: Up to $100,000 salary support per year for two years for 50% protected time to pursue a mentored educational project at the home institution.
• Professional Development and Project Expenses: Scholars receive $25,000 per year for two years to subsidize the cost of professional development activities and related project expenses.

Career Stage: Early career

Purpose: 
The Macy Faculty Scholars Program aims to identify and nurture promising early-career educators in medicine and nursing. The program seeks to accelerate Scholars’ careers, to turn their teaching practice into scholarship, and to help them become impactful leaders locally, nationally and beyond.

Program highlights over two years include:

• Salary support and protected time to pursue a mentored education project
• Professional development and project support
• Formal mentoring
• Invitation to the MFS Annual Meeting for past and present scholars
• Educational opportunities
• Access to Macy grantees and programs

---

G. Harold and Leila Y. Mathers Foundation – Limited Submission

Fall 2026 Deadline:
Letter of intent due July 31, 2026, 8p.m. ET
If invited, full proposal due September 18, 2026, 8p.m. ET

Funding: $700,000 over three years

Purpose:
The Mathers Foundation supports basic research with translational potential in areas such as immunology, microbiome, structural biology, cancer, genetics, stem cells and neuroscience. The foundation funds work that can lead to major advances in scientific understanding and human health.

Eligibility

• Institutions that directly support their own investigators
• Principal investigators with their own fully equipped labs
• All levels of professorship
• Collaborative research projects with other U.S.-based organizations

Margaret Q. Landenberger Research Foundation – Internal Competition

Internal deadline: Internal applications are to be submitted via Drexel’s InfoReady Funding Portal no later than August 7, 11:59 p.m.

Funder's deadline: October 2, 2026 at 5 p.m.

Funding: Grants are generally $200,000, over a two year period

Purpose:
The Margaret Q. Landenberger award is intended for early-stage investigators who have completed their terminal research degree or end of post-graduate clinical training, whichever date is later, within the past 10 years. This is not a mentored award, and individuals who are currently on K awards or the equivalent are not eligible for funding. The ideal candidate would be an assistant or associate professor who has had a K award or equivalent and is now seeking independent funding such as an R award. K99/R00 awardees may apply during the R00 phase.

The Landenberger Foundation is open to research in all fields.

---

Damon Runyon Fellowship Award

Deadline: August 14, 2026,4PM ET

Funding: Total funding $300,000 (Year 1: $72,000; Year 2: $74,000; Year 3: $76,000; Year 4: $78,000)

Career Stage: Early career

Purpose:
Damon Runyon views cancer research very broadly, including the full spectrum of basic questions important to normal human biology and carcinogenesis, as well as development of new platforms and technologies. The foundation encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention including molecular approaches to cancer prevention for inherited cancers. The foundation seeks novel ideas and approaches.

Eligibility: Postdoctoral Fellows

---

Elsa U. Pardee Foundation

Deadlines:

• August 31, 2026
• December 1, 2026

Career Stage: Early and established career

Funding:
By design, there are no limits set on the amount that can be requested. It must be reasonably supported by the scope of the project outlined in the application. Indirect costs cannot exceed 5% of the total amount requested.

Description:
The Elsa U. Pardee Foundation funds research to investigators in United States nonprofit institutions proposing research directed toward identifying new treatments or cures for cancer. The foundation funds projects for a one-year period, which will allow the establishment of capabilities of new cancer researchers or new cancer approaches by established cancer researchers. It is anticipated that this early-stage funding by the Foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment or cure should be clearly identified. The foundation particularly welcomes innovative, small-scale, short-term projects that may be difficult to fund elsewhere until some interesting results are obtained.

Eligibility:
Priority is given to researchers at nonprofit institutions in the United States who are new to the field of cancer research, or to established research investigators examining new approaches to cancer cure.

Cancer Research Institute
CRI Irvington Postdoctoral Fellowship Program – LIMITED SUBMISSION

Deadlines: September 1, 2026, and March 1, 2027

Funding:
Fellowships provide three years of support, including a stipend of $74,000, $76,000, and $78,000 in years 1 through 3. The host institution receives a $5,000 annual allowance for use at the sponsor’s discretion to cover costs such as research supplies, conference travel, health insurance or childcare.

Purpose:
The CRI Irvington postdoctoral fellowship program supports outstanding young researchers at the world’s leading universities and research institutions, providing the resources, mentorship and professional development needed to launch independent scientific careers at the forefront of discovery.

Eligibility:

• Applicants must have a doctoral degree by the date of award activation and must conduct their proposed research under a sponsor who holds a formal appointment as an assistant professor or higher rank at the host institution.
• Applicants must be working in areas directly related to immunology or cancer immunology. An eligible project must fall into the broad field of immunology with relevance to solving the cancer problem.
• Applicants who will have five or more years of mentored research experience at the time of award activation are not eligible, with the exception of MD applicants, who should not include years of residency in this calculation. Applicants should use their doctoral degree conferral date when calculating eligibility.
• Only in exceptional circumstances will applicants who have already spent three or more years in a sponsor’s laboratory by the start date of thefellowship be considered for a fellowship award.
• The fellowship can be performed in the United States or abroad but must take place at a nonprofit institution. There are no citizenship restrictions.
• Only one fellow per sponsor may apply per application round, and faculty sponsors may not have more than three CRI-supported fellows at any time.

---

Wings for Life Grant Application

Deadline: September 1, 2026 (Executive Summary); If invited, grant application due 11/2/26.

Purpose:
Basic research projects may address the following aspects of traumatic spinal cord injury:

• Nerve regeneration/plasticity
• Neuronal and glial protection
• Functional deficits induced by lesions
• Preferentially in mammalian models
• Preferentially on mechanisms present/validated in humans

A preference is given to research projects that have:

• A perspective of translation from the laboratory to the clinical setting
• The potential to provide real benefits to spinal cord injury patients
• A focus on chronic spinal cord injury, in case applicable

Individual Grant:
Wings for Life will provide absolute costs as indicated. Fringe benefits, training andtuition fees can be included up to the maximum sum and need to be specified and indicated in different lines of the budget form. Wings for Life also requires proof of the requested fringe benefits, training and tuition fees.

• The maximum amount for a postdoc is 100,000 EUR/year
• The maximum amount for PhD student is 60,000 EUR/year
• The maximum amount for technicians is 45,000 EUR/year

Project Grant:
The maximum funding period for a project grant is three years. After two years the applicant has to submit a scientific report/extension application; the funding for the third year depends on its evaluation.

Maximum sum per grant is 130,000 € per year all inclusive. Indirect costs (overhead costs) are limited to 10% of direct costs (equipment, products, animals and animal care, fringe costs, etc.).

---

Cancer Research Institute
CRI Immuno-Informatics Postdoctoral Fellowship: Cultivating the next generation of leaders at the Intersection of immunology and data science.

Deadline: September 1, 2026

Funding: $228,000 over three years

Career Stage: Early career

Purpose:
The CRI Immuno-Informatics Fellowship is designed to support:

• Computational biologists seeking to deepen their understanding of immunology.
• Cancer immunologists aiming to gain expertise in computational biology, data science and/or genomics.
• Researchers from diverse PhD backgrounds pursuing training at the interface of cancer immunology and computational biology.

Eligibility:

• Applicants must have a doctoral degree by the date of award activation and must conduct their proposed research under a sponsor who holds a formal appointment as an assistant professor or higher rank at the host institution.
• Applicants must be working in areas directly related to immunology or cancer immunology. An eligible project must fall into the broad field of immunology with relevance to solving the cancer problem.
• Applicants who will have five or more years of mentored research experience at the time of award activation are not eligible, with the exception of MD applicants, who should not include years of residency in this calculation. Applicants should use their doctoral degree conferral date when calculating eligibility.

---

BrightFocus Foundation
Alzheimer’s Disease Research Postdoctoral Fellowship

Deadline:
September 1, 2026, 5 p.m.

Funding
Postdoctoral Fellowship Award: Around $200,000 total over two years (salary, benefits and research-related costs)

Career Stage
Early career (postdoctoral fellows within five years of degree or residency completion)

Purpose
This Alzheimer’s Disease Research Fellowship supports postdoctoral training for early-career basic or clinician-scientists pursuing innovative research in Alzheimer’s disease. The program is designed to foster the development of independent research careers by funding fellows working under the guidance of a mentor within a structured training environment. Awards prioritize the fellow’s development, emphasizing applicant productivity, mentor quality, training plan strength, and the scientific merit of the proposed research. Funding supports salary, health insurance, and travel to scientific meetings, as well as research-related expenses when supplemental salary funding exists. The fellowship aims to advance high-impact, early-stage research while building the next generation of Alzheimer’s disease investigators.

Eligibility
Applicants must hold (or be completing) an MD, PhD, or equivalent and have the title of Postdoctoral Fellow (or equivalent) by the start of the award. Candidates must be within 5 years of degree conferral or residency completion (with limited extensions allowed). A mentor and individualized training plan are required. Applicants may apply with a pending appointment if confirmed before the award begins. Fellowships must be conducted at academic, nonprofit, government, or for-profit research institutions. Each laboratory may hold only one active fellowship and one standard award at a time.

---

BrightFocus Foundation
Alzheimer’s Disease Research – Standard Awards

Deadline: September 1, 2026, 5 p.m. ET

Funding: $100,000 per year for up to three years

Career Stage: Early Career; Independent Investigator

Purpose:
The BrightFocus Foundation research grants program supports innovative, high-risk, high-reward research focused on advancing understanding, prevention and treatment of Alzheimer’s disease and related dementias (as well as macular degeneration and glaucoma). The program prioritizes novel, investigator-initiated projects that address critical gaps in knowledge and have the potential to significantly advance the field. Through relatively small, early-stage grants, BrightFocus enables researchers to generate preliminary data needed to compete for larger government or industry funding. Incremental or well-established lines of research are discouraged in favor of bold, exploratory ideas with strong potential impact.

Eligibility
Applicants must serve as principal investigator with independent research capacity and dedicated lab space at an eligible institution (academic, nonprofit, governmental or for-profit). The program includes two tracks: Early Career (within 15 years of degree) and Independent Investigator (beyond early career and without active R01-equivalent funding for similar work). Applicants must hold an MD, PhD or equivalent degree. Only one standard award and one fellowship may be held per lab at a time. Applications should demonstrate scientific rigor, innovation and relevance to Alzheimer’s disease and related dementias.

---

Alzheimer’s Drug Discovery Foundation

Deadline: Letter of intent due September 14, 2026

Funding:

• Up to $5,000,000 based on stage and scope of research. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged. Payment structure will be negotiated and based on milestone achievements and recruitment.
• Average Duration - Multi-year
• Only direct costs are allowed.

Purpose:
The Drug Development RFP supports investigational new drug-enabling studies (or the international equivalent) and early-phase clinical trials that test promising pharmacological interventions and devices for Alzheimer’s disease and related dementias. This funding opportunity concentrates on diverse drug mechanisms and modes of action related to the biology of aging and other emerging therapeutic areas for dementia.

Eligibility:

• Industry partnerships are strongly encouraged.
• Funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones.

Whitehall Foundation

As of July 2026, eligibility is restricted exclusively to researchers at the assistant professor level, with a preference for those just beginning their careers.

Deadline:  Letter of intent due October 1, 2026. If invited, full application due February 15, 2027.

Funding:
Up to $300,000. The maximum budget is $100,000 per year for the two- and three-year research grants.

Purpose:
Research grants are available to investigators that meet all of the foundation’s eligibility requirements and are working at accredited institutions in the United States. Applications will be judged on the scientific merit and the innovative aspects of the proposal, as well as on the competence of the applicant. Research grants of up to three years will be provided. A renewal grant with a maximum of two years is possible, but it will be awarded on a competitive basis. Research grants will not be awarded to investigators who have already received, or expect to receive, substantial support from other sources, even if it is for an unrelated purpose. The maximum budget is $100,000 per year for the two- and three-year research grants.

Eligibility
The applicant must meet all four of the following eligibility requirements in order to participate in the application process:

1. Appropriate title – must hold the title of assistant professor. If the institution does not use this title, a letter from the department chair confirming the applicant's eligibility is required.
2. Independence – to be eligible for consideration an applicant must be considered an "independent investigator," as defined by the National Institutes of Health. The foundation assesses independence based on the faculty appointment, commitment of the institution to the PI as an individual member of the faculty, and the allocation of lab space that is independent and free from the control of other members of the faculty. Each application will be assessed on its own merits, but our emphasis on independence is particularly important when an applicant is continuing at the same institution as their doctoral or postdoctoral advisor. Please note that the foundation does not consider lab space located within a former mentor’s or advisor's lab to be sufficiently independent, even with the title of assistant professor or assistant research professor. These expectations are in line with the foundation’s goal of supporting young investigators as they launch their careers.
3. Status – must hold principal investigator status.
4. The foundation does not fund investigators who have substantial (more than $200,000 per year) extramural funding calculated as total direct funds per year less any PI salary/fringe taken from these grants. If this amount is greater than $200,000, the PI is not be eligible for Whitehall Foundation funding. As of December 1, 2024, the foundation no longer includes indirect funding in the extramural funding calculation. Startup funds and internal funding should be disclosed but are not included in the extramural funding calculation.

It is the Whitehall Foundation’s policy that an investigator must be in place, working at their institution with the appropriate title, when the letter of intent is submitted.

Grants in Aid
The Grants-in-Aid program is designed for researchers who experience difficulty in competing for research funds because they have not yet become firmly established. All applications will be judged on the scientific merit and innovative aspects of the proposal, as well as on past performance and evidence of the applicant’s continued productivity. Grants-in-Aid are awarded for a one-year period and do not exceed $30,000.

Applicants for the Grants-in-Aid program are reviewed and ranked together with the traditional research grant program. This program is not a prerequisite to a two- or three-year research grant. The majority of the applications received are for a three-year research grant.

---

Campbell Foundation – Limited Submission

Deadline: October 1, 2026
Due to our funding limitations, we are only able to consider LOIs from one research team at any given institution within a one-year time frame.

Funding:
Most grant funding is between $60,000 and $100,000. The foundation has co-funded and has provided partial funding for more costly research projects.

Purpose:
The Campbell Foundation invites letters of intent for its research grants that support novel research relevant to the HIV community at large within five to seven years from date of completion.

It was Mr. Zahn's wish that his private, independent foundation support nonprofit organizations conducting clinical, laboratory-based research into the prevention and treatment of HIV/AIDS, and related conditions and illnesses.

Eligibility:
Funding is restricted to those organizations providing proof of IRS 501(c)(3) status. Applications are not accepted from individuals or for-profit entities.

Additional deadlines: LOIs are accepted during January, April, July and October of each year.

---

McKnight Foundation – Neurobiology of Brain Disorders Award

Deadline: Applications open: August 3, 2026. Deadline: October 15, 2026, 5 p.m. CT

Funding: $100,000 per year for three years

Purpose
For scientists translating laboratory discoveries about the brain and nervous system into diagnoses and therapies to improve human health.

Eligibility
A candidate for a McKnight Neurobiology of Brain Disorders Award must work as an independent investigator at a not-for-profit research institution in the United States, must have held a tenured or tenure-track faculty position for at least three years at the time of application (no later than September 2023), and must wait at least one year before reapplying after two unsuccessful concurrent applications.

American Cancer Society – Postdoctoral Fellowships

Deadline: December 1, 2026

Funding: Progressive stipends of $66,000, $68,000, and $70,000 for up to three years, plus an annual $4,000 fellowship allowance and $1,500 travel allowance in the final year.

Purpose: Postdoctoral fellowships support new investigators in research training programs to position them for independent careers in cancer research. As part of their evaluation, peer reviewers consider how well the fellowship will broaden the applicant’s research training and experience.

Eligibility: Investigators who are U.S. citizens or non-citizens holding an appropriate visa when the application is submitted and who have completed three or fewer years of postdoctoral research training.

---

W.M. Keck Foundation – Limited Submission

Deadline: December 7, 2026

New Application Process:
The W. M. Keck Foundation Research program is introducing a new six-month application cycle to enable more responsive grantmaking and create a streamlined process for applicants.

Important changes to be aware of:

• Concepts: We will no longer be hosting concept consultations.
• Single-phase application: A single proposal submission replacing our current multi-stage process.
• Deadlines: Submission deadlines in December and June
• Application limits: Up to three applications per institution, not limited to any area of science.

Instructions for constructing and submitting proposals will be available in September.

Funding:

• Typical awards: $1 million to $1.3 million over three years
• Two limited submission funding cycles per year
• No indirect costs — institution provides in-kind support by waiving indirects

Funding Priorities

• High-impact research in basic physical, life and biomedical sciences, including instrumentation and engineering in service of basic science.
• Pioneering, fundamental discoveries in important and emerging research areas
• Novel approaches that are distinctive, innovative, field-expanding and challenge existing paradigms
• High-risk, high-reward proposals are welcome

Eligibility:

• PIs must be tenure-track faculty or equivalent (normally eligible to submit proposals without exceptional approvals)
• Past grantees may apply on significantly different projects
• No resubmission of declined proposals
• No follow-on funding for previous awards

Cancer Research Institute – CRI Lloyd J. Old STAR Program

Deadline: January 15, 2027

Funding: $1.25 million over a five-year period; indirect costs of up to 10%

Purpose:
The CRI Lloyd J. Old STAR program — Scientists TAking Risks — provides long-term, flexible funding to mid-career scientists, giving them the freedom to pursue high-risk, high-reward research at the leading edge of cancer immunotherapy.

Eligibility:
The applicant must have an MD, PhD, or MD/PhD (or equivalent). Candidates must hold a tenure-track position. Assistant professors with a minimum of three years in that role and associate professors with a maximum three years may apply. Applicants are expected to commit a minimum of 80% of their time to conducting research.

Simons Foundation – New Ideas Award

Deadline: Letters of intent (LOI) will be accepted on a rolling basis

Funding: $300,000 per year for up to two years; includes 20% indirect costs

Purpose:
The goal of the New Ideas Award is to provide early-stage support for bold, exploratory research that tests novel hypotheses and opens new conceptual or experimental directions in the study of autism and related neurodevelopmental disorders. Proposed research may draw on any scientific discipline, methodology or experimental system (including humans), and may operate at any scale or level of analysis. All projects should include a compelling case for the relevance and potential of the proposed experiments to SFARI’s mission. Investigators who have not previously been funded by SFARI are especially encouraged to apply.

Eligibility
All applicants and key collaborators must hold a PhD, MD or equivalent degree and have a faculty position or the equivalent at a college, university, medical school or other research facility. We encourage both applicants who have long been working in autism research and those new to the field.

---

Michael J. Fox Foundation
Parkinson’s Disease Therapeutics Pipeline Program

Deadline:

• Applicants may submit a pre-proposal application at any time. Pre-proposals will be reviewed by MJFF within three weeks of submission.
• If invited, full proposal is to be submitted through one of the five review cycles:
  • April 23, 2026
  • June 25, 2026
  • August 20, 2026

Funding: $250,000 for smaller, targeted programs to upwards of $2M for larger, multi-stage preclinical and/or clinical programs.

Purpose:
This program seeks to advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease (PD). The program is set up to benefit therapeutics with clear potential to prevent, stop or delay disease progression or to reduce the burden of daily symptoms.

MJFF prioritizes pre-clinical and clinical programs that may slow, stop or prevent disease
progression, efforts that address moderate-to-advanced motor or non-motor symptoms of
Parkinson’s not well-managed by current treatments, such as advanced gait disturbances (e.g., balance issues linked to falls, freezing), and cognitive changes. Activities within scope of this program include:

• Pre-clinical: Identifying, validating and/or developing novel pharmacological and nonpharmacological interventions through pre-clinical development from early screening to pre-clinical characterization and testing.
• Clinical: Progressing promising interventions with strong preclinical packages into/through initial clinical assessment exploring pharmacokinetics and pharmacodynamics, safety/tolerability, or early proof of biology and/or clinical efficacy. For novel targets, MJFF is particularly interested in de-risking programs by supporting early proof of concept in patients to gain insight into the therapeutic potential, including exploration of biomarker-based or clinical endpoint-based efficacy

Eligibility:
The foundation is only accepting applications from industry groups or academic teams working in collaboration with a dedicated industry partner capable of further commercial development of a promising intervention. Further, our goal is to provide funding to de-risk therapeutic programs and catalyze investment by other funders. We do not anticipate serving as the sole funder for any program and encourage applicants to seek additional financial partnerships.

---

Michael J. Fox Foundation

The Alzheimer’s Association and the Michael J. Fox Foundation for Parkinson’s Research are launching the Bridge Funding for Disrupted Neurodegenerative Research (BFDN) grant program.

Deadline: 15th of the month (or the following Monday, if the 15th falls on a weekend).
If invited, full proposal deadline will be within four weeks of receiving the invitation by 5 p.m. ET. If invited, full proposal deadline will be within four weeks of receiving the invitation by 5 p.m. ET.

Funding: Principal investigators may apply for bridge funding spanning three to 12 months for U.S. and international projects impacted by changes in the NIH.

Career Stage: Early Career

Purpose:
This program specifically aims to 1) ensure support for early career researchers (based on NIH definition), who have not yet had the opportunity to fully establish their labs and position their projects for ongoing funding, and 2) provide bridge or interim funding for salary and other direct costs for research projects focused on Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease, dementia with Lewy bodies, atypical Parkinson's and/or other related disorders that have been impacted by a series of changes at NIH.

---

Cardiovascular Medical Research and Education Fund
Improving the Treatment of Pulmonary Diseases

Deadline: Rolling

Funding:
Preference will be given to proposals that have budgets below $100,000 and timelines less than two years.

Purpose:
The CMREF mission of the fund is to support educational activities that will enhance the knowledge of pulmonary hypertension and research projects that may help uncover the causes and pathogenesis of idiopathic pulmonary arterial hypertension (IPAH) in pursuit of the ultimate goal of its treatment and cure. The CMREF does not have a formal application process to fund clinical research or educational projects but is always interested in potentially providing full or partial support to initiatives that are novel, innovative or address the spectrum of unmet medical needs related to pulmonary vascular diseases.

Interested parties should submit a letter of intent (maximum of two pages) that describes the project sufficiently so that the Research Advisory Committee can understand the proposed goals and methods. In addition, the letter should mention the length of time of the project and an estimated overall budget.

How to Apply:
To submit your letter, please use the form on this page. Please be sure to fill out all fields and upload your letter before submitting. You can also email your letter directly to Patt Wolfe (executive director) at patt.wolfe@ipahresearch.org.

After you submit your letter, the CMREF will respond within four weeks to inform you if a full application will be requested.

---

American Federation for Aging Research
Medical Student Training in Aging Research (MSTAR) Program

Deadline:
Interested students should be in touch directly with the National Training Centers to for the program deadline and application materials.

Funding:
The stipend level is approximately $1,980 per month; actual amounts will vary based on the specific appointment period of individual students. Award period: Eight to 12 weeks.

Purpose:
The MSTAR Program provides medical students with an enriching experience in aging-related research and geriatrics, with the mentorship of top experts in the field. This program introduces students to research and academic experiences early in their training that they might not otherwise have during medical school. Positive experiences in the MSTAR program have led many physicians-in-training to pursue academic careers in aging, ranging from basic science to clinical research to health services research. They have joined the growing cadre of physicians and scientists whose specialized knowledge and skills are in great demand as our population ages.

Students participate in an eight- to twelve-week (or two- to three-month, depending on the training site) structured research, clinical and didactic program in geriatrics, appropriate to their level of training and interests. Research projects are offered in basic, translational, clinical or health services research relevant to older people. Most scholars will do their training and research during the summer months. They will also be invited to submit an abstract to present a poster at the annual meeting of the American Geriatrics Society.

Eligibility

• Any allopathic or osteopathic medical student in good standing, who will have successfully completed one year of medical school at a U.S. institution by June 2024. Evidence of good standing must be provided by the medical school registrar or dean when the student is notified of receiving the award.
• Applicants must be citizens or non-citizen nationals of the United States, or must have been lawfully admitted for permanent residence (i.e., in possession of a currently valid Alien Registration Receipt Card I-551, or some other legal verification of such status). Individuals on temporary or student visas are not eligible. Due to NIA restrictions, individuals holding PhD, MD, DVM or equivalent doctoral degrees in the health sciences are not eligible to apply to do the MSTAR Program.
• Additionally, applicants receiving a stipend or salary support from a federal source are not eligible for this program. Applicants may not hold another award or participate in another program concurrently with the MSTAR program, and must participate in the program full-time for a minimum of eight weeks and a maximum of 12 weeks.

---

Infectious Diseases Society of America
Grants for Emerging Researchers/Clinicians Mentorship Program

Career Stage: Medical Students

Amount: Not specified

Deadline: Ongoing

Description
The G.E.R.M. Program was developed to provide grants to medical students to support a longitudinal, mentored clinical learning and/or research project for up to a year on infectious diseases-related topics, including HIV, under the mentorship of an IDSA or HIVMA member. This program replaced the IDSA Medical Scholars and HIVMA Medical Students Programs.

Eligibility

• Graduate students
• Applicants must be medical students (first-, second- or third-year and those in combined degree programs, including MD/MPH and MD/PhD) from an accredited allopathic or osteopathic medical school in the U.S.

 Back to Top